Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia.

Authors :: Prebet T
Bertoli S
Delaunay J
Pigneux A
Delabesse E
Mozziconacci MJ
Bidet A
Recher C
Vey N
Source :: Haematologica [Haematologica] 2014 Oct; Vol. 99 (10), pp. e185-7. Date of Electronic Publication: 2014 Jun 27.
Publication Year :: 2014

Subjects :: Core Binding Factors genetics
Humans
Leukemia, Myeloid, Acute genetics
Leukemia, Myeloid, Acute mortality
Remission Induction
Treatment Outcome
Anthracyclines administration & dosage
Antineoplastic Agents administration & dosage
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools